Skip to content

Trial Estimating the Efficiency of the Light Therapy in Brain Trauma Sequel Fatigue

Controlled Randomized Trial Estimating the Efficiency of Blue Enriched White Light on Sequel Fatigue, in Victims of Severe Cranial Traumas

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02420275
Acronym
phototrauma
Enrollment
20
Registered
2015-04-17
Start date
2015-05-11
Completion date
2017-12-01
Last updated
2017-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse Brain Injury

Keywords

brain injury, blue enriched withe bright light therapy, sequel fatigue

Brief summary

After a brain injury (BI) , patients complain in particular about sequel fatigue. This symptom affects about 50 % of the patients; it is severe, with a repercussion on quality of life, reeducation and occupational reintegration, and persists often at a distance of the accident. The investigators' hypothesis is that patients who presented a severe BI could benefit from a treatment by withe blue enriched bright light in order to improve fatigue and quality of life.

Detailed description

After a BI , patients complain in particular about sequel fatigue. This symptom affects about 50 % of the patients; it is severe, with a repercussion on quality of life, reeducation and occupational reintegration, and persists often at a distance of the accident. The investigators' hypothesis is that patients who presented a severe BI could benefit from a treatment by blue enriched withe bright light in order to improve fatigue and quality of life. The main objective is to decrease fatigue and the secondary objectives are to improve quality of life,decrease daytime sleepiness and increase vigilance. This is a randomized clinical trial with 2 groups blue enriched withe bright light versus nothing) including 20 patients.The treatment will take 8 weeks with 30 minutes exposition at awakening to withe blue enriched bright light (Luminette, Belgium). The investigators willl estimate the fatigue severity scale score , the quality of life the score (SF12), the sleepiness Epworth score, and the Psychomotor Vigilance Task (PVT) The investigators will included patient with severe BI more than six months after the BI.

Interventions

OTHERplacebo

THIS GROUP WILL RECEIVE NO BRIGHT LIGHT

DEVICELuminette,Lucimed Belgium

THIS GROUP WILL RECEIVE BLEU LIGHT ENRICHIDED IN WITHE BRIGHT LIGHT

Sponsors

Fondation Garches
CollaboratorOTHER
Centre d'Investigation Clinique et Technologique 805
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Severe brain injury patients more than 6 months after the trauma * Out of the phase of post-traumatic amnesia (score in Galveston Orientation and Amnesia Test (GOAT) upper to 75) * Initial score on the Glasgow coma scale inferior or equal to 8 within the first 24 hours after brain injury, except sedation * Age from 18 to 65 years old * Fatigue severity score ( FSS) superior or equal to 4 and/or a score on the sleepiness Epworth scale superior or equal to 10 and/or a score to the quality questionnaire of sleep of Pittsburg \> in 5 * Having given a writing informed consent * Registered on the Social Security

Exclusion criteria

* Non-stabilized psychiatric neurological affection and/or endocrine diseases or drug addiction * Major depression diagnosed with the MINI depression scale * Cognitive, behavioural or motor disorders incompatible with use of phototherapy glasses * Night workers or transméridien journey in the last month * Chronic fatigue syndrome before the accident * Deafness * Major obesity (BMI \> 33) * High risk of apnea syndrome in the Berlin questionnaire * Consumption of long half-l hypnotics or stimulants * Treatments with antidepressants are tolerated if the dose is stable during all the participation on approval and for at least one month before the inclusion. * Eye lesion, in particular of the retina * Photosensibility

Design outcomes

Primary

MeasureTime frameDescription
Fatigue Severity Scale30 minutesFatigue measure by fatigue severity scale

Secondary

MeasureTime frameDescription
Epworth slumber scale30 minutesSubjective Slumber measured by Epworth slumber scale
Analog visual scales10 minutessubjective slumber measured by Epworth slumber scale
Psychomotor Vigilance Task15 minutesvigilance measured by Psychomotor Vigilance Task
P30030 minutesCognitive evoked potential measure by P300

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026